Navigation Links
PharmaPoint: Multiple Sclerosis - US Drug Forecast and Market Analysis to 2022
Date:5/14/2013

The US is the largest MS market due to the high prevalence of the disease and comparatively high MS drug prices.During the forecast period, the major driver for market growth is an increase in the diagnosis rate following adoption of the revised 2010 McDonald criteria, which greatly reduced the time to diagnosis, and the push by physicians for the earlier initiation of treatment in patients. Other important drivers include the launch of several pipeline DMTs that provide improved efficacy and convenient administration, as well as increased accessibility to treatment due to US healthcare reform, which will both result in higher treatment rates. Furthermore, the launch of novel DMTs that specifically target progressive MS, such as masitinib and siponimod, will also increase treatment uptake by patients with PPMS or SPMS. With several key patent expiries of leading branded products occurring throughout the forecast period, generic erosion will be the biggest barrier to market growth.

Scope

- Overview of the Multiple Sclerosis including epidemiology, etiology, symptoms, diagnosis, pathology and treatment guidelines as well as an overview on the competitive landscape.- Detailed information on the key drugs in the US including product description, safety and efficacy profiles as well as a SWOT analysis.- Sales forecast for the top drugs in the US from 2012-2022.- Analysis of the impact of key events as well the drivers and restraints affecting the US Multiple Sclerosis market.

Reasons to buy

- Understand and capitalize by identifying products that are most likely to ensure a robust return- Stay ahead of the competition by understanding the changing competitive landscape for Multiple Sclerosis- Effectively plan your M&A and partnership strategies by identifying drugs with the most promising sales potential- Make more informed business decisions from insightful and in-depth analysis of drug performance- Obtain sales forecast for dru
'/>"/>

SOURCE Reportlinker
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6

Related medicine technology :

1. PharmaPoint: Multiple Sclerosis - China Drug Forecast and Market Analysis to 2022
2. PharmaPoint: Osteoporosis - US Drug Forecast and Market Analysis to 2022
3. PharmaPoint: Osteoporosis - India Drug Forecast and Market Analysis to 2022
4. In Relapsed/Refractory Multiple Myeloma, Thought Leaders Are Optimistic that the Combination of Carfilzomib, Lenalidomide and Dexamethasone Will Be the Most Efficacious Regimen
5. Hobart Group Holdings Marks 10th Anniversary With Multiple Milestones
6. Mapi Pharma Granted United States Patent Covering Glatiramer Depot for Multiple Sclerosis
7. For Pharma Companies, Launching Multiple Similar Products Can Be a "Good Problem" but Requires Smart Resourcing
8. Deploying an Effective Pay for Performance Bonus System that Works Across Multiple Industry Sectors
9. Aurigene Announces Transition of Multiple Programs to Clinical Development in its Collaboration Business
10. Omeros Announces that GPR17 Antagonists Improve Function in Model of Multiple Sclerosis
11. Surveyed U.S. Neurologists Would Prescribe Biogen Idecs Tecfidera to 20 Percent of Their Patients with Relapsing-Remitting Multiple Sclerosis (RR-MS)
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/4/2015)... 2015 GSI Group Inc. (NASDAQ: ... leader and supplier of precision photonics and motion control ... industrial technology markets, today reported financial results for the ... all financial results in this press release are GAAP ... the fourth quarter of 2014, GSI generated revenue of ...
(Date:3/4/2015)... PARK, Calif. , March 4, 2015  Nevro ... company that has developed and commercialized an innovative, evidence-based ... announced that it will release financial results for the ... close on Wednesday, March 18, 2015. Company management will ... Time (4:30 p.m. Eastern Time) on Wednesday, March 18, ...
(Date:3/4/2015)... , March 4, 2015 The March 3, 2015, order ... drugs must change their products, labels to clarify the drugs, ... attack and stroke is necessary to protect the public from ... a partner at Simmons Hanly Conroy . ... labels that the products – currently taken by millions of ...
Breaking Medicine Technology:GSI Group Announces Financial Results for the Fourth Quarter and Full Year 2014 2GSI Group Announces Financial Results for the Fourth Quarter and Full Year 2014 3GSI Group Announces Financial Results for the Fourth Quarter and Full Year 2014 4GSI Group Announces Financial Results for the Fourth Quarter and Full Year 2014 5GSI Group Announces Financial Results for the Fourth Quarter and Full Year 2014 6GSI Group Announces Financial Results for the Fourth Quarter and Full Year 2014 7GSI Group Announces Financial Results for the Fourth Quarter and Full Year 2014 8GSI Group Announces Financial Results for the Fourth Quarter and Full Year 2014 9GSI Group Announces Financial Results for the Fourth Quarter and Full Year 2014 10GSI Group Announces Financial Results for the Fourth Quarter and Full Year 2014 11GSI Group Announces Financial Results for the Fourth Quarter and Full Year 2014 12GSI Group Announces Financial Results for the Fourth Quarter and Full Year 2014 13GSI Group Announces Financial Results for the Fourth Quarter and Full Year 2014 14GSI Group Announces Financial Results for the Fourth Quarter and Full Year 2014 15GSI Group Announces Financial Results for the Fourth Quarter and Full Year 2014 16GSI Group Announces Financial Results for the Fourth Quarter and Full Year 2014 17GSI Group Announces Financial Results for the Fourth Quarter and Full Year 2014 18GSI Group Announces Financial Results for the Fourth Quarter and Full Year 2014 19GSI Group Announces Financial Results for the Fourth Quarter and Full Year 2014 20GSI Group Announces Financial Results for the Fourth Quarter and Full Year 2014 21GSI Group Announces Financial Results for the Fourth Quarter and Full Year 2014 22GSI Group Announces Financial Results for the Fourth Quarter and Full Year 2014 23GSI Group Announces Financial Results for the Fourth Quarter and Full Year 2014 24GSI Group Announces Financial Results for the Fourth Quarter and Full Year 2014 25GSI Group Announces Financial Results for the Fourth Quarter and Full Year 2014 26GSI Group Announces Financial Results for the Fourth Quarter and Full Year 2014 27GSI Group Announces Financial Results for the Fourth Quarter and Full Year 2014 28GSI Group Announces Financial Results for the Fourth Quarter and Full Year 2014 29GSI Group Announces Financial Results for the Fourth Quarter and Full Year 2014 30GSI Group Announces Financial Results for the Fourth Quarter and Full Year 2014 31GSI Group Announces Financial Results for the Fourth Quarter and Full Year 2014 32GSI Group Announces Financial Results for the Fourth Quarter and Full Year 2014 33Simmons Hanly Conroy, LLC: FDA Orders Label Warnings on Testosterone Drugs Concerning Normal Aging Use and Heart Attack-Stroke Risks 2
... Corporation (NASDAQ: HSKA ; "Heska"), a leading ... to veterinarians, announced today the intent to collaborate with ... disorders.  The parties are to explore unique technologies in ... use in the veterinary market.      "Heska ...
... 14, 2011 Berger Health System, recognized as one ... Association, upgrades to AutoCarousel® HD by Talyst, a leader ... control, and has a built-to-last 10 years guarantee. ... five years, is also implementing AutoPharm®, AutoPack™ and AutoLabel® ...
Cached Medicine Technology:Heska Announces Exploration of New Technologies Through Strategic Collaboration with Entegrion, Inc. 2Heska Announces Exploration of New Technologies Through Strategic Collaboration with Entegrion, Inc. 3Berger Health System Partners With Pharmacy Automation Leader to Improve Patient Safety 2
(Date:3/4/2015)... March 04, 2015 Ultraman Florida is ... mile swim, 261.4 mile bike, and 52.4 mile run. ... time of 24:45:45. , "This race was awesome and ... wonderful team and sponsors for supporting me through every ... 2015 had a total of 40 select participants invited ...
(Date:3/4/2015)... Dr. Christopher Asandra, M.D., Founder and Chief Medical ... the FDA’s recent decision to issue a warning ... FDA’s conclusions are not supported by science, and that ... deficiency. , “The FDA appears to have developed a ... Dr. Asandra. “There is not nearly enough evidence to ...
(Date:3/4/2015)... 2015 TROY Healthcare Solutions will be ... the ultimate level of security for prescriptions, in Houston, ... Plaza Medical Center located at 6633 Travis Street from ... 7 AM, TROY Healthcare Solutions will host a continental ... offer brief presentations each hour to introduce attendees to ...
(Date:3/4/2015)... March 04, 2015 Cook For Your ... that teaches healthy cooking to people touched by cancer, ... Lodge. The program, run by founder Ann Ogden, will ... Sport Management. The unique partnership will expand the program ... founded CFYL in 2007. After going through her own ...
(Date:3/4/2015)... 2015 Smokers across America are the ... 'We Love Smokers' from Aqua-Tine, the new brand that ... "It’s important to establish a clear point of view ... idea, 'We Love Smokers' elevates the Aqua-Tine brand, gives ... created a bold tone of voice that is also ...
Breaking Medicine News(10 mins):Health News:Living Fuel Champion Christian Isakson Finishes Second In UltraMan Florida Test of Endurance 2Health News:NuMale’s Dr. Christopher Asandra: FDA Suffering from “Premature Equivocation” on Issue of Testosterone and Risks 2Health News:TROY Healthcare to Offer Prescription Solutions that can save a Hospital $100,000 2Health News:TROY Healthcare to Offer Prescription Solutions that can save a Hospital $100,000 3Health News:Drexel University and Cook for Your Life Team Up 2Health News:Drexel University and Cook for Your Life Team Up 3Health News:Drexel University and Cook for Your Life Team Up 4Health News:Drexel University and Cook for Your Life Team Up 5Health News:The Brand Behind The Bold and Provocative Ad Campaign 'We Love Smokers' 2Health News:The Brand Behind The Bold and Provocative Ad Campaign 'We Love Smokers' 3
... March 24 Epiphany Biosciences announced today that ... the Food and Drug Administration (FDA) to study ... valomaciclovir (EPB-348) as an adjunctive therapy in the ... possess potent antiviral activity in vitro against a ...
... Reverse Split Ratio of Outstanding Cellegy Common Stock Expected ... Cellegy Pharmaceuticals, Inc. (OTC Bulletin Board: CLGY) today announced ... Corporation approved the previously announced merger of the two ... The transaction, which is subject to customary closing ...
... to be affected into 2010, according to Millennium ... Millennium Research Group,s (MRG,s) US Markets for Small-Joint ... elbow, digit, ankle, and wrist) and arthrodesis devices ... seen in recent years will continue despite the ...
... According to a new Harris Interactive/HealthDay poll, the ... afford medical care and prescription medications.(1) In addition, a ... Americans went without needed prescription medications in 2007 due to ... Experts predict these statistics are likely to get worse in ...
... , ... Dallas (Vocus) March 24, 2009 -- Broadlane announced ... with Broadlane. Wuesthoff will continue to access Broadlane,s unparalleled national ... help manage its approximate $53 million in annual spend for its ...
... March 24 Regal International, Inc., doing business ... been appointed by EMK Products, LLC to be ... Care Product line. Under the agreement, Beauty Beverly ... the development and management of internet affiliates, marketing ...
Cached Medicine News:Health News:Epiphany Biosciences Initiates Program to Assess Valomaciclovir (EPB-348) as Adjunctive Therapy in Multiple Sclerosis (MS) 2Health News:Cellegy and Adamis Stockholders Approve Merger Transaction and Related Proposals 2Health News:Cellegy and Adamis Stockholders Approve Merger Transaction and Related Proposals 3Health News:Job Loss Means Fewer Americans Have Health Care Coverage: How Will the Economic Downturn Affect the Small-Joint Implant Market? 2Health News:*** Diabetes Alert Day *** OneTouch(R) Offers Cost Saving Tips to Help Diabetes Patients Maintain Good Health in Tough Economy 2Health News:*** Diabetes Alert Day *** OneTouch(R) Offers Cost Saving Tips to Help Diabetes Patients Maintain Good Health in Tough Economy 3Health News:*** Diabetes Alert Day *** OneTouch(R) Offers Cost Saving Tips to Help Diabetes Patients Maintain Good Health in Tough Economy 4Health News:Wuesthoff Health System and Broadlane Continue Exclusive Relationship; Orthopedic Consulting Initiative Yields Significant Savings 2Health News:Wuesthoff Health System and Broadlane Continue Exclusive Relationship; Orthopedic Consulting Initiative Yields Significant Savings 3Health News:Wuesthoff Health System and Broadlane Continue Exclusive Relationship; Orthopedic Consulting Initiative Yields Significant Savings 4Health News:EMK Placental Appoints Beauty Beverly Hills for Exclusive Distributorship. 2Health News:EMK Placental Appoints Beauty Beverly Hills for Exclusive Distributorship. 3
... System provides easy-to-use features, auto iris, white ... camera head construction is based on Solos ... 1-Chip Camera System, Domestic (GS 9900-NTSC) includes: ... with power cord and video cables , ...
... The 3-Chip Camera System offers 800+ ... generator, auto iris, automatic gain control, and ... , ,Complete 3-Chip Camera System for ... , (MS 1000-01) Camera Control Unit (CCU) ...
Provides a combination of concentrated cold / hot and compression for the elbow...
Provides a combination of concentrated cold / hot and compression for the neck...
Medicine Products: